American Century Companies’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.92M | Buy |
298,984
+1,255
| +0.4% | +$33.3K | ﹤0.01% | 1465 |
|
|
2025
Q1 | $7.19M | Sell |
297,729
-3,853
| -1% | -$93.1K | ﹤0.01% | 1444 |
|
|
2024
Q4 | $12.1M | Buy |
301,582
+25,824
| +9% | +$1.04M | 0.01% | 1263 |
|
|
2024
Q3 | $17.5M | Buy |
275,758
+2,309
| +0.8% | +$146K | 0.01% | 1081 |
|
|
2024
Q2 | $14.5M | Sell |
273,449
-558,683
| -67% | -$29.6M | 0.01% | 1091 |
|
|
2024
Q1 | $68.2M | Sell |
832,132
-1,391,690
| -63% | -$114M | 0.04% | 446 |
|
|
2023
Q4 | $41.4M | Buy |
2,223,822
+21,594
| +1% | +$402K | 0.03% | 567 |
|
|
2023
Q3 | $24.4M | Buy |
2,202,228
+822,156
| +60% | +$9.1M | 0.02% | 733 |
|
|
2023
Q2 | $22.4M | Buy |
1,380,072
+1,355,183
| +5,445% | +$22M | 0.02% | 724 |
|
|
2023
Q1 | $431K | Buy |
24,889
+5,544
| +29% | +$96.1K | ﹤0.01% | 2180 |
|
|
2022
Q4 | $182K | Buy |
+19,345
| New | +$182K | ﹤0.01% | 2354 |
|
|
2020
Q1 | – | Sell |
-574,424
| Closed | -$4.61M | – | 1729 |
|
|
2019
Q4 | $4.61M | Buy |
574,424
+260,768
| +83% | +$2.09M | ﹤0.01% | 815 |
|
|
2019
Q3 | $2.16M | Buy |
313,656
+18,918
| +6% | +$130K | ﹤0.01% | 960 |
|
|
2019
Q2 | $2.45M | Buy |
294,738
+57,272
| +24% | +$475K | ﹤0.01% | 995 |
|
|
2019
Q1 | $2.36M | Sell |
237,466
-10,750
| -4% | -$107K | ﹤0.01% | 970 |
|
|
2018
Q4 | $1.9M | Sell |
248,216
-5,753
| -2% | -$44K | ﹤0.01% | 981 |
|
|
2018
Q3 | $4.42M | Buy |
+253,969
| New | +$4.42M | ﹤0.01% | 883 |
|